adverse effect of semaglutide icd-10 Cardiometabolic and Renal Outcomes in Users with Type 2 Diabetes Achieving Glycemic and Weight Goals: An Observational Cohort Study | Advances in Therapy Wegovy (semaglutide) - Dosing, PA

Both accounts follow the same IRS rules for what counts as a qualified medical expense, and thats where the GLP-1 question gets specific

Mean change in bodyweight from baseline at week 40 was -69 kg with semaglutide 20 mg and -60 kg with semaglutide 10 mg (ETD -093 kg [95% CI -168 to -018]

Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: a multicentre, prospective real-world study (PIONEER REAL Canada)

In both groups, adverse effects were typically mild and transient, predominantly nausea

Upper Arm (Outer) Typically administered by a healthcare provider